This Institute Colloquium is offered as a webinar. If you would like to attend this webinar, please register below.
In the first half year of the SARS-CoV-2 pandemic, rapid progress has been made in understanding human B cell responses and serum antibodies targeting this new virus. Dr. Boyd will provide an update on this area of research and the diagnostic and therapeutic implications of humoral immune responses in patients with COVID-19.